Clinical Trial: Bioequivalence Study of GZR4 Injection With Different Manufacturing Processes in Healthy Adult Participants

U.S., June 27 -- ClinicalTrials.gov registry received information related to the study (NCT07670897) titled 'Bioequivalence Study of GZR4 Injection With Different Manufacturing Processes in Healthy Adult Participants' on June 22.

Brief Summary: This study is a single-center, open-label, randomized, single-dose bioequivalence trial conducted in healthy adult participants.

Study Start Date: July 01

Study Type: INTERVENTIONAL

Condition: T2D

Intervention: DRUG: GZR4 injection A

GZR4 s.c., single-dose

DRUG: GZR4 injection B

GZR4 s.c., single-dose

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Gan & Lee Pharmaceuticals.

Published by HT Digital Content Services with permission from Health Daily Digest....